Jean-Luc M. Lemercier, CVP, EMEACLA and JAPAC at Edwards Lifesciences Corp (EW), sold 13,608 shares at $88.68 ($1.2M) on 2023-05-09, disclosed to the SEC on 2023-05-09.
Scheduled sale ($1.2M) by CVP, EMEACLA and JAPAC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.74 | 224 | $20K | 1.6% |
| 2 | $88.74 | 104 | $9K | 0.8% |
| 3 | $88.68 | 6,640 | $589K | 48.8% |
| 4 | $88.68 | 6,640 | $589K | 48.8% |
| Total | $88.68 avg | 13,608 | $1.2M | 100% |
| Filing → |
| EW | SELL | 2024-03-11 | $1.3M | — | Filing → |
| EW | SELL | 2023-04-06 | $552K | — | Filing → |
| EW | SELL | 2023-03-08 | $1.0M | — | Filing → |